Skip to content
10-K/A

Annual Report

PARALLAX HEALTH SCIENCES, INC.

0001388410-20-000053

← back to feed
Filed
May 20, 2020 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 15, 2020 270.72M sh
Shares Diluted FY 2019 · Dec 31, 2019 261.53M sh
Shares Diluted FY 2019 · Dec 31, 2018 215.58M sh
Operating Cash Flow FY 2019 · Dec 31, 2019 −$2.95
Operating Cash Flow FY 2019 · Dec 31, 2018 −$1.29M
Long Term Debt FY 2019 · Dec 31, 2019 $760.15K
Long Term Debt restated FY 2019 · Dec 31, 2018 $934.02K
Cash And Equivalents FY 2019 · Dec 31, 2019 $6.45K
Cash And Equivalents FY 2019 · Dec 31, 2018 $262
Stockholders Equity FY 2019 · Dec 31, 2019 −$10.25M
Stockholders Equity restated FY 2019 · Dec 31, 2018 −$5.95M
Current Liabilities FY 2019 · Dec 31, 2019 $7.72M
Current Liabilities restated FY 2019 · Dec 31, 2018 $5.12M
Total Liabilities FY 2019 · Dec 31, 2019 $11.61M
Total Liabilities restated FY 2019 · Dec 31, 2018 $7.31M
Current Assets FY 2019 · Dec 31, 2019 $58.62K
Current Assets FY 2019 · Dec 31, 2018 $262
Total Assets FY 2019 · Dec 31, 2019 $1.36M
Total Assets FY 2019 · Dec 31, 2018 $1.36M
Sga Expense FY 2019 · Dec 31, 2019 $6.51M
Sga Expense restated FY 2019 · Dec 31, 2018 $6.63M
Net Income FY 2019 · Dec 31, 2019 −$12.87M
Net Income restated FY 2019 · Dec 31, 2018 $14.78M
Operating Income FY 2019 · Dec 31, 2019 −$6.39M
Operating Income restated FY 2019 · Dec 31, 2018 −$6.63M
Gross Profit FY 2019 · Dec 31, 2019 $111.77K
Gross Profit FY 2019 · Dec 31, 2018 −$8.6K
Cost Of Revenue FY 2019 · Dec 31, 2019 $16.83K
Cost Of Revenue FY 2019 · Dec 31, 2018 $20.34K
Revenue FY 2019 · Dec 31, 2019 $128.6K
Revenue FY 2019 · Dec 31, 2018 $11.74K